Biogen, Inc. (BIIB)
168.57
-0.74
(-0.44%)
USD |
NASDAQ |
Jan 15, 16:00
166.76
-1.81
(-1.07%)
After-Hours: 04:24
Biogen Price: 168.57 for Jan. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1032.97 |
| Stoke Therapeutics, Inc. | 29.28 |
| AbbVie, Inc. | 216.75 |
| Alnylam Pharmaceuticals, Inc. | 359.26 |
| Insmed, Inc. | 159.27 |
Price Related Metrics
| PE Ratio | 15.37 |
| PS Ratio | 2.551 |
| Price to Book Value | 1.358 |
| Price to Free Cash Flow | 10.93 |
| Earnings Yield | 6.50% |
| Market Cap | 24.73B |
| Operating PE Ratio | 10.13 |
| Normalized PE Ratio | 13.63 |